` Comparison: INFE vs 1949 - Alpha Spread

C
INFE
vs
1949

Over the past 12 months, INFE has significantly outperformed Sumitomo Densetsu Co Ltd, delivering a return of +33% compared to the Sumitomo Densetsu Co Ltd's 99% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
INFE
1949
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

INFE Intrinsic Value
HIDDEN
Show
Sumitomo Densetsu Co Ltd Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
C
Cie Industrielle Financiere Entreprise SA
PAR:INFE
71 EUR
Sumitomo Densetsu Co Ltd
TSE:1949
9 700 JPY
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
INFE, 1949

INFE
1949
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
C
Cie Industrielle Financiere Entreprise SA
Revenue
Sumitomo Densetsu Co Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
INFE, 1949

INFE
1949
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
C
Cie Industrielle Financiere Entreprise SA
PAR:INFE
Sumitomo Densetsu Co Ltd
TSE:1949
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

INFE
48.7%
Sumitomo Densetsu Co Ltd
17.2%

Operating Margin

INFE
4.6%
Sumitomo Densetsu Co Ltd
10.9%

Net Margin

INFE
5.2%
Sumitomo Densetsu Co Ltd
7.7%

FCF Margin

INFE
6.2%
Sumitomo Densetsu Co Ltd
4.4%

ROE

INFE
23.2%
Sumitomo Densetsu Co Ltd
14.7%

ROA

INFE
4.3%
Sumitomo Densetsu Co Ltd
8.9%

ROIC

INFE
4.3%
Sumitomo Densetsu Co Ltd
16.9%

ROCE

INFE
10%
Sumitomo Densetsu Co Ltd
18.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
INFE, 1949

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
INFE, 1949

Performance Gap Between INFE and 1949
HIDDEN
Show

Performance By Year
INFE, 1949

Loading
INFE
1949
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare INFE to other stocks
PWR
Quanta Services Inc
More expensive
vs INFE
DG
Vinci SA
More expensive
vs INFE
LTO
Larsen and Toubro Ltd
More expensive
vs INFE
LT
Larsen & Toubro Ltd
More expensive
vs INFE
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett